Medicines Reconciliation at an Intensive Care Unit

NCT ID: NCT03173690

Last Updated: 2017-07-11

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 50 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-02-06
• Study Completion Date: 2017-10-31

Brief Summary

This study evaluates the effect of performing medicines reconciliation on patients admitted to an intensive care unit. Half of the patients will receive a medicines reconciliation at the intensive care unit. The other half will not. All included patients will receive medicines reconciliation after transfer to the ward.

Detailed Description

Transfer of patients from one level of care to another is known to increase the risk of medication errors. Medication reconciliation is an accepted intervention to increase the knowledge on the patients medication use, thus reducing the risk of avoidable medication errors. For patients in the intensive care unit treatment of the imminent threat is obviously the most important. Nevertheless, knowledge about previous medications are important.

Conditions

Medicines Reconciliation; Intensive Care Unit

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: SINGLE

Study Groups

Intervention group

Receive medication reconciliation at the ICU, pluss medication reconciliation at the ward

Group Type: EXPERIMENTAL

Medication reconciliation at the ICU

Intervention Type: OTHER

Medication reconciliation performed according to Integrated Medicines Management model

Medication Reconciliation at the Ward

Intervention Type: OTHER

Medication reconciliation performed according to Integrated Medicines Management model

Control group

No intervention at the ICU, medication reconciliation at the ward

Group Type: OTHER

Medication Reconciliation at the Ward

Intervention Type: OTHER

Medication reconciliation performed according to Integrated Medicines Management model

Interventions

Medication reconciliation at the ICU

Medication reconciliation performed according to Integrated Medicines Management model

Intervention Type: OTHER

Medication Reconciliation at the Ward

Medication reconciliation performed according to Integrated Medicines Management model

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• belonging to the hospitals intake area
• written informed concent by the patient or his/her next to kin

Exclusion Criteria

• Patients without next to kin
• Not Norwegian speaking, in need of a translator
• medication reconciliation performed earlier
• Patients with Guillain-Barre or Myasthenia Gravis, due to long expectancy of stay
• Short life expectancy, decided in cooperation with the physician

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hospital Pharmacy Enterprise, South Eastern Norway

OTHER

Sponsor Role: collaborator

University Hospital, Akershus

OTHER

Sponsor Role: lead

Responsible Party

Silje Engdal Ørnes

Clinical pharmacist, Ph.d

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Silje E Oernes, PhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Pharmacy Enterprise, South Eastern Norway

Locations

Akershus university Hospital

Lørenskog, Akershus, Norway

Site Status: RECRUITING

Countries

Norway

Central Contacts

Silje E Oernes, phD

Role: CONTACT

silje.engdal.ornes@sykehusapotekene.no

004767960302

Facility Contacts

Per Martin Baadstolokken

Role: primary

Other Identifiers

16-186

Identifier Type: -

Identifier Source: org_study_id